222 related articles for article (PubMed ID: 23300522)
21. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor.
Bokoch MP; Zou Y; Rasmussen SG; Liu CW; Nygaard R; Rosenbaum DM; Fung JJ; Choi HJ; Thian FS; Kobilka TS; Puglisi JD; Weis WI; Pardo L; Prosser RS; Mueller L; Kobilka BK
Nature; 2010 Jan; 463(7277):108-12. PubMed ID: 20054398
[TBL] [Abstract][Full Text] [Related]
22. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
23. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography.
Wacker D; Fenalti G; Brown MA; Katritch V; Abagyan R; Cherezov V; Stevens RC
J Am Chem Soc; 2010 Aug; 132(33):11443-5. PubMed ID: 20669948
[TBL] [Abstract][Full Text] [Related]
24. Energy Landscapes Reveal Agonist Control of G Protein-Coupled Receptor Activation via Microswitches.
Fleetwood O; Matricon P; Carlsson J; Delemotte L
Biochemistry; 2020 Feb; 59(7):880-891. PubMed ID: 31999436
[TBL] [Abstract][Full Text] [Related]
25. Stereoselective binding of agonists to the β
Plazinska A; Plazinski W
Mol Biosyst; 2017 May; 13(5):910-920. PubMed ID: 28338133
[TBL] [Abstract][Full Text] [Related]
26. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
Plazinska A; Kolinski M; Wainer IW; Jozwiak K
J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
[TBL] [Abstract][Full Text] [Related]
27. In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.
Vilar S; Karpiak J; Berk B; Costanzi S
J Mol Graph Model; 2011 Apr; 29(6):809-17. PubMed ID: 21334234
[TBL] [Abstract][Full Text] [Related]
28. Structural features of β2 adrenergic receptor: crystal structures and beyond.
Bang I; Choi HJ
Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861
[TBL] [Abstract][Full Text] [Related]
29. Modeling GPCR active state conformations: the β(2)-adrenergic receptor.
Simpson LM; Wall ID; Blaney FE; Reynolds CA
Proteins; 2011 May; 79(5):1441-57. PubMed ID: 21337626
[TBL] [Abstract][Full Text] [Related]
30. Ligand entry and exit pathways in the beta2-adrenergic receptor.
Wang T; Duan Y
J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
[TBL] [Abstract][Full Text] [Related]
31. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
[TBL] [Abstract][Full Text] [Related]
32. Conformational changes in the G protein Gs induced by the β2 adrenergic receptor.
Chung KY; Rasmussen SG; Liu T; Li S; DeVree BT; Chae PS; Calinski D; Kobilka BK; Woods VL; Sunahara RK
Nature; 2011 Sep; 477(7366):611-5. PubMed ID: 21956331
[TBL] [Abstract][Full Text] [Related]
33. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.
Bhattacharya S; Hall SE; Li H; Vaidehi N
Biophys J; 2008 Mar; 94(6):2027-42. PubMed ID: 18065472
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterol.
Szczuka A; Wennerberg M; Packeu A; Vauquelin G
Br J Pharmacol; 2009 Sep; 158(1):183-94. PubMed ID: 19594756
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of the β₂-adrenergic receptor is determined by conformational equilibrium in the transmembrane region.
Kofuku Y; Ueda T; Okude J; Shiraishi Y; Kondo K; Maeda M; Tsujishita H; Shimada I
Nat Commun; 2012; 3():1045. PubMed ID: 22948827
[TBL] [Abstract][Full Text] [Related]
36. Comparative Docking to Distinct G Protein-Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy.
Scharf MM; Bünemann M; Baker JG; Kolb P
Mol Pharmacol; 2019 Dec; 96(6):851-861. PubMed ID: 31624135
[TBL] [Abstract][Full Text] [Related]
37. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor.
Yao X; Parnot C; Deupi X; Ratnala VR; Swaminath G; Farrens D; Kobilka B
Nat Chem Biol; 2006 Aug; 2(8):417-22. PubMed ID: 16799554
[TBL] [Abstract][Full Text] [Related]
38. Modeling the possible conformations of the extracellular loops in G-protein-coupled receptors.
Nikiforovich GV; Taylor CM; Marshall GR; Baranski TJ
Proteins; 2010 Feb; 78(2):271-85. PubMed ID: 19731375
[TBL] [Abstract][Full Text] [Related]
39. Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors.
Nivedha AK; Tautermann CS; Bhattacharya S; Lee S; Casarosa P; Kollak I; Kiechle T; Vaidehi N
Mol Pharmacol; 2018 Apr; 93(4):288-296. PubMed ID: 29367258
[TBL] [Abstract][Full Text] [Related]
40. Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists.
Freddolino PL; Kalani MY; Vaidehi N; Floriano WB; Hall SE; Trabanino RJ; Kam VW; Goddard WA
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2736-41. PubMed ID: 14981238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
